Teva (TEVA) Q2 2025 Earnings Report

62 Followers

IL:TEVA Q2 2025 EPS Results

Actual EPS: ILA 208.16
Consensus EPS: ILA 194.60
Beat/Miss: Beat by +ILA 13.56
One Year Ago EPS: ILA 192.39

IL:TEVA Q2 2025 Revenue Results

Actual Revenue: ILA 1.51T
Expected Revenue: ILA 1.35T
Beat/Miss: Beat by +ILA 159.36B
YoY Revenue Growth: -2.83%

Earnings Announcement Details

Quarter: Q2 2025
Date: 07/30/2025
Time: Before Open
Conference Call: Wednesday, July 30, 2025

IL:TEVA Upcoming Earnings

Teva's next earnings date is estimated for February 10, 2027, based on past reporting schedules.

Q2 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2025 Earnings Call Summary

No earnings call summary is available for this earnings event.

IL:TEVA Earnings History

IL:TEVA earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Feb 10, 2027	2026 (Q4)	211.31-	302.77	―	―
Nov 03, 2026	2026 (Q3)	227.40271.24	246	10.26% (+25.23)
Jul 29, 2026	2026 (Q2)	16.406.31	208.16	-96.97% (-201.85)
Apr 29, 2026	2026 (Q1)	148.55167.16	164	1.92% (+3.15)
Jan 28, 2026	2025 (Q4)	202.16302.77	223.93	35.21% (+78.85)
Nov 05, 2025	2025 (Q3)	217.62246.00	217.62	13.04% (+28.39)
Jul 30, 2025	2025 (Q2)	194.60208.16	192.39	8.20% (+15.77)
May 07, 2025	2025 (Q1)	145.71164.00	151.39	8.33% (+12.62)
Jan 29, 2025	2024 (Q4)	222.98223.93	315.39	-29.00% (-91.46)
Nov 06, 2024	2024 (Q3)	208.47217.62	189.23	15.00% (+28.39)
Jul 31, 2024	2024 (Q2)	174.10192.39	176.62	8.93% (+15.77)
May 08, 2024	2024 (Q1)	162.11151.39	126.16	20.00% (+25.23)
Jan 31, 2024	2023 (Q4)	242.22315.39	223.93	40.85% (+91.46)
Nov 08, 2023	2023 (Q3)	191.76189.23	186.08	1.69% (+3.15)
Aug 02, 2023	2023 (Q2)	165.58176.62	214.47	-17.65% (-37.85)
May 10, 2023	2023 (Q1)	175.67126.16	173.46	-27.27% (-47.31)
Feb 08, 2023	2022 (Q4)	225.50223.93	242.85	-7.79% (-18.92)
Nov 03, 2022	2022 (Q3)	676.83186.08	186.08	0.00% (+0.00)
Jul 27, 2022	2022 (Q2)	628.26232.70	192.1	21.13% (+40.60)
May 03, 2022	2022 (Q1)	563.29184.40	204.9	-10.00% (-20.50)
Feb 09, 2022	2021 (Q4)	739.90246.90	221.3	11.57% (+25.60)
Oct 27, 2021	2021 (Q3)	654.12188.20	195.8	-3.88% (-7.60)
Jul 28, 2021	2021 (Q2)	607.76192.10	187.1	2.67% (+5.00)
Apr 28, 2021	2021 (Q1)	―204.90	267	-23.26% (-62.10)
Feb 10, 2021	2020 (Q4)	―221.30	212.9	3.95% (+8.40)
Nov 05, 2020	2020 (Q3)	―195.80	202.8	-3.45% (-7.00)
Aug 05, 2020	2020 (Q2)	―187.10	208.8	-10.39% (-21.70)
May 07, 2020	2020 (Q1)	―267.00	215.8	23.73% (+51.20)
Feb 12, 2020	2019 (Q4)	―212.90	193.3	10.14% (+19.60)
Nov 07, 2019	2019 (Q3)	―202.80	251.7	-19.43% (-48.90)
Aug 07, 2019	2019 (Q2)	―208.80	287.8	-27.45% (-79.00)
May 02, 2019	2019 (Q1)	―215.80	340.9	-36.70% (-125.10)
Feb 13, 2019	2018 (Q4)	―193.30	325.5	-40.61% (-132.20)
Nov 01, 2018	2018 (Q3)	―251.70	350.3	-28.15% (-98.60)
Aug 02, 2018	2018 (Q2)	―287.80	367.1	-21.60% (-79.30)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Teva earnings date